CD Biosynsis specializes in the engineering of robust and tightly-regulated Inducible Expression Systems across a diverse range of host organisms. These systems are crucial for applications requiring precise, on-demand control over gene expression, such as manufacturing toxic proteins, optimizing metabolic pathway flux, or producing unstable therapeutic molecules. We offer comprehensive services, including the rational design and tuning of promoter-regulator pairs, selection of optimal induction conditions, and genomic integration for stability. Our expertise ensures low basal expression (leakiness) in the OFF state and high expression levels in the ON state, delivering maximum control and efficiency for your protein or metabolite production needs in both research and industrial settings.
Get a QuoteInducible expression systems provide temporal and dosage control, allowing researchers to decouple cell growth from product synthesis, which is vital for maximizing yields and mitigating toxicity. Our engineering efforts focus on optimizing the key components: the Inducible Promoter (which controls expression strength), the Regulator (the protein that binds the promoter), and the Inducer (the chemical signal). We can tune the dynamic range, induction speed, and dose-response curve of the system using advanced synthetic biology techniques, including promoter library construction and ribosome binding site (RBS) optimization. Whether you require a chemically-induced system (e.g., lac, tet, arabinose) or a physical one (e.g., temperature, light), our services ensure the system integrates cleanly into the host genome for stable, leak-proof performance.
Check the box next to your desired host and stability:
E. coli Expression System
Yeast (S. cerevisiae/Pichia)
Mammalian Cell Lines (HEK/CHO)
Algae/Cyanobacteria
Stable Genomic Integration
High-Copy Plasmid System
Single-Use/Transient Expression
Polycistronic Expression Units
Select the induction method suitable for your application:
IPTG (lac Operon)
Tetracycline/Doxycycline (tet ON/OFF)
Arabinose (ara Operon)
Temperature Shock (e.g., cI857)
Phosphate Limitation (phoA)
Methanol (AOX1 Promoter in Pichia)
Light-Inducible Systems (Optogenetics)
Custom Natural Metabolite Induction
Basal Leakiness Reduction
Engineering the regulator-operator affinity to minimize unwanted expression in the uninduced state (OFF state).
Promoter Dynamic Range Tuning
Construction and screening of promoter libraries to select variants providing the optimal ON-state expression level for the application.
Co-factor Balancing & Toxin Mitigation
Engineering metabolic pathways to prevent the accumulation of toxic intermediates or balance co-factor availability (e.g., NADH/NADPH) upon induction.
A systematic process for designing and validating tightly regulated gene expression.
Design & Component Selection
Build & System Assembly
Test & Kinetic Characterization
Optimization & Integration
Target Analysis: Determine required expression level (high/low), required ON/OFF ratio, and acceptable basal leakiness.
Component Selection: Choose the optimal promoter, regulator, and inducer based on host compatibility and toxicity of the target product.
Synthetic Assembly: Construct the complete expression cassette, including optimized RBS and genomic integration sites, using synthetic biology tools.
Initial Host Transformation: Introduce the expression system into the host, prioritizing stable genomic integration via CRISPR-Cas or homologous recombination.
Dose-Response Curve: Characterize the system by testing expression across a range of inducer concentrations to determine the dynamic range.
Time-Course Analysis: Monitor expression kinetics over time (e.g., growth phase, induction period) to find the optimal induction time point.
Near-Zero Basal Leakiness
Systems are rigorously engineered to prevent unwanted expression of toxic or unstable products during the cell growth phase.
Tunable Expression Level
Allows precise modulation of gene dosage, crucial for optimizing metabolic flux and balancing pathway intermediate concentrations.
High Final Titer
Decoupling growth and production ensures optimal cell mass is achieved before induction, maximizing the final product yield.
Stable Genomic Integration
Systems are stably integrated into the host chromosome, ensuring long-term genetic stability without plasmid loss during scale-up.
"The engineered Tightly Controlled Expression System solved our product toxicity problem completely. The basal expression was virtually zero, allowing us to hit much higher cell densities before induction."
Dr. Alan Rivas, Head of Bioprocess Development, Biotech Pharma
"Their work on our Multi-Gene Cascade Design was phenomenal. They successfully synchronized the expression of five different pathway enzymes with a single, low-cost inducer."
Ms. Sophia Chen, Lead Synthetic Biologist, Specialty Chemicals
"We needed a system that was non-responsive to glucose. The custom Orthogonal Regulator they designed proved to be incredibly robust and predictable in our complex media."
Mr. Ben Carter, CTO, Sustainable Materials Research
"We commissioned CD Biosynsis to support an intricate gene editing project with multiple targets. Their talent in producing high-quality work in a short period of time was impressive. Their solutions were custom made to suit our needs, and they went above and beyond to ensure our experiments worked. Their support has been a great asset to our research department and we look forward to further working with them."
Dr. Raj Patel, Principal Investigator, Department of Molecular Biology
"As a pharmaceutical company working to discover new cancer therapies, we require accurate, trustworthy gene editing solutions. CD Biosynsis did more than what we expected when it came to providing strong, accurate CRISPR/Cas9 solutions for our preclinical research. Their technical support team was excellent and responsive, and they quickly replied to our questions. This alliance has been pivotal in helping us move our drug pipeline forward. Thank you, CD Biosynsis, for your amazing service!"
Dr. Clara Rodriguez, Chief Scientist, AstraZeneca Pharmaceuticals, Spain
Why is low basal leakiness so important?
Low basal leakiness (expression in the OFF state) is crucial, especially when the target product is toxic to the cell (e.g., membrane proteins, certain antibiotics). Any leaky expression during the initial growth phase can slow down or kill the host cell, dramatically reducing the final biomass and, consequently, the final product titer.
What is the difference between tet ON and tet OFF systems?
In a tet OFF system, the regulator (tTA) is active and represses the promoter when tetracycline/doxycycline is absent; adding the inducer turns the system OFF. In a tet ON system, the regulator (rtTA) is inactive and only becomes active in the presence of the inducer, turning the system ON. We can engineer either system based on your needs.
Can you engineer systems for industrial, low-cost inducers?
Yes. While IPTG is common, its cost can be prohibitive at scale. We focus on engineering systems that utilize low-cost, food-grade inducers (like L-arabinose or rhamnose) or even endogenous metabolic signals, making the system economically viable for large-scale biomanufacturing.
How do you integrate the system into the host genome?
For most hosts, we use advanced CRISPR-Cas or specialized homologous recombination systems to precisely insert the entire expression cassette (promoter, gene, regulator) into a specific, neutral site on the host chromosome. This guarantees high stability, consistency, and eliminates the need for antibiotic selection markers typically associated with plasmids.
How much does Metabolic Engineering services cost?
The cost of Metabolic Engineering services depends on the project scope, complexity of the target compound, the host organism chosen, and the required yield optimization. We provide customized quotes after a detailed discussion of your specific research objectives.
Do your engineered strains meet regulatory standards?
We adhere to high quality control standards in all strain construction and optimization processes. While we do not handle final regulatory approval, our detailed documentation and compliance with best laboratory practices ensure your engineered strains are prepared for necessary regulatory filings (e.g., GRAS, FDA).
What to look for when selecting the best gene editing service?
We provide various gene editing services such as CRISPR-sgRNA library generation, stable transformation cell line generation, gene knockout cell line generation, and gene point mutation cell line generation. Users are free to select the type of service that suits their research.
Does gene editing allow customisability?
Yes, we offer very customised gene editing solutions such as AAV vector capsid directed evolution, mRNA vector gene delivery, library creation, promoter evolution and screening, etc.
What is the process for keeping data private and confidential?
We adhere to the data privacy policy completely, and all customer data and experimental data are kept confidential.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.